# Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

> **NCT06631625** · PHASE1 · COMPLETED · sponsor: **Alexandria University** · enrollment: 45 (actual)

## Conditions studied

- Pelvic Cancer
- Abdominal Cancer
- Surgery
- Proinflammatory Cytokines

## Interventions

- **DRUG:** Lidocaine Intravenous Infusion
- **DRUG:** Lidocaine and ketamine
- **DRUG:** lidocaine and dexmedetomidine infusion

## Key facts

- **NCT ID:** NCT06631625
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-24
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06631625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06631625, "Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06631625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*